Is AI Destined to Replace Fund Managers?
In this episode of TechTalk, we talk about the debut of the world’s first ETF powered by artificial intelligence (AI). We discuss the technology behind it, if it impacts a fund’s expense ratio and, most importantly, how it’s performing.
Dave Plaskow: Hello and welcome to EisnerAmper’s technology podcast series. With more than 500 technology clients, we’re always interested in the latest industry trends and developments, as well as any related business and accounting opportunities and challenges. Today’s topic is robot managed mutual funds. I’m your host Dave Plaskow and with us today is Dave Katz, senior manager in EisnerAmper’s technology and life sciences practice. It’s another episode of The Dave & Dave Show. Dave, welcome and thanks for being here.
Dave Katz: Always good to be here Dave.
DP: I like this topic – it seems really interesting to me. But are we now moving one step closer to robots taking over the world?
DK: It sure does seem that way sometimes. In this case, San Francisco-based EquBot LLC debuted the world’s first ETF powered by artificial intelligence. It’s the AI Powered Equity ETF. It’s on the New York Stock Exchange under ticker AIEQ.
DP: Great. And what’s the technology behind this?
DK:Using the data processing power of IBM’s Watson, the fund ranks investment opportunities by analyzing more than one million pieces of information daily such as economic data, consumer trends, social media posts, and world and company-specific news, and it identifies those equities with the greatest potential for appreciation. The technology builds predictive models on some 6,000 companies and then derives a portfolio of approximately 70 U.S. equities.
DP: Okay. But this isn’t an entirely new concept, is it?
DK:No, computer algorithms have been examining trading patterns in stocks for quite a while now.
DP:What’s different here?
DK:The AI uses machine learning so it can actually learn without the assistance of people.
DP: Wow. Now, with all the automation behind this, is this going to lower the price of funds?
DK:Somewhat. The AI-powered equity ETF has an annual expense ratio of about 0.75%. That’s a little higher than the average passive ETF, but for actively traded funds, such as this, it’s a little cheaper.
DP: Now the real question, how’s the fund doing?DK:Yes, that’s what everyone wants to know. In its first week of trading, the fund was up 1%. During that same time period, the S&P 500 index was up 0.5%, so score this one for the robots. But the fund only has about $7 million in assets. Should it be successful, we’ll obviously see that number grow.
DP: We’re seeing in a lot of media reports that artificial intelligence may put quite a few people across a variety of sectors out of work. Is this now one step closer to putting flesh-and-blood fund managers out of business?
DK:Certainly the decrease in actively managed funds and increase in index and target date funds have been a challenge for the fund manager workforce. And while AI will replace certain positions, I think there will always be a need for highly skilled professionals to provide personal services to clients – the key word being “personal.”
DP: So we’ll have to keep our eyes open and see if this starts going more mainstream, moving into the Fidelity and Vanguards of the world.
DP: Well, Dave, thanks for your expertise and great insight.
DP: And thank you for listening to The Dave & Dave Show, as part of the EisnerAmper podcast series. Visit EisnerAmper.com for more information on this, and a host of other topics. And join us for our next EisnerAmper podcast, when we get down to business.
Dave Katz, Senior Manager in EisnerAmper’s Technology and Life Sciences practice, talks about the rise and fall of Theranos. He explains what took them from biotech unicorn to dissolution, the fallout, and how companies and investors can mitigate risk.
In this episode of the Dave & Dave Show, we look at New York City’s proposed annual cap on the number of ride-sharing vehicles, such as Uber and Lyft, and the larger implications for this unique urban initiative.
Cryptocurrency still has the reputation for significant price swings. In this episode of the Dave & Dave Show, we look at a new contender—with some big backers—that’s tied to the U.S. dollar to help temper that volatility.
TechTalk takes a look at a tech startup, Aerobotics, that is using drones to help farmers in South Africa.
In this episode of TechTalk, we look at a 3D-printed housing community for needy families in El Salvador, the goals are, some of the attached business issues, and how this could be a technological game-changer for affordable housing.
The Dave and Dave Show looks at 23andMe’s DNA test-taking kit, its recent approval by the FDA to scan for certain breast cancer genes, where the market is headed, and what it means for the biotech industry and its business advisors.
TechTalk examines a few interesting things Amazon is up to on its march toward global e-tail domination, such as its choosing a city for its new headquarters, its foray into health care, Amazon Go and more.
This episode of TechTalk, we cover a unique, FDA-approved EKG device for the Apple Watch. We’ll discuss the science and the business behind this promising new technology, as well as how the market for smart watches is doing.
In this final TechTalk podcast of 2017, we examine the technology headlines that caught our attention toward the end of the year, including net neutrality, the data hack at Uber, some misbehaving drones and what might be on the menu for 2018.
The iPhone X has put a renewed spotlight on facial recognition technology. Dave Katz gives us a history on this type of technology, some of the privacy and security issues, what the market looks like and which companies are leading the charge.
In this episode of TechTalk, we discuss the technology and financing issues related to the possible return of supersonic air travel.
Will the robot vacuum collect customer household data and offer it to technology companies to enhance internet of things devices? Here is what information is being collected, potential data privacy and security issues, and iRobot’s response to consumer concerns.
In this episode of TechTalk, Dave Katz tells us about electric car company Tesla receiving a significant investment from Chinese technology giant Tencent.
TechTalk discusses recent mergers and acquisitions in e-commerce including Amazon's recent acquisition of Souq, a Dubai based e-commerce company.
With tech jobs are estimated to double over the next decade, we discuss the market for tech talent and what the forecast for tech employment looks like.
Dave Katz, Senior Audit Manager in EisnerAmper’s Technology and Life Sciences Practice, and Richard Colloca, Partner-in-Charge of EisnerAmper’s Food and Beverage Group, discuss Amazon’s plan to use 'Just Walk Out Technology.'
David Katz gives a “state of the union” on self-driving cars, an overview of Uber’s unique experiment in Pittsburgh, and a glimpse of what we can expect in the marketplace.
In this episode of TechTalk, we learn about the real estate shortage for biotech hubs, the challenges of obtaining new space, how early-stage companies are coping, and what’s on the drawing board to help alleviate the shortage.
In this episode of TechTalk, we discuss space-age technology that could revolutionize personal travel and commercial traffic.
David in EisnerAmper's Technology and Life Sciences Practice, discusses the commercial drone market, including potential markets, barriers to entry and where capital investment is headed.
We discusses some of the financial aspects of virtual reality, such as investment, valuation, revenue recognition and more.